Slice – Multi‑Gene (2‑150 genes)
Use
The GeneDx “Slice – Multi‑Gene (2‑150 genes)” test captures and sequences the entire exome but limits analysis to a custom‐built gene list specified by the provider, enabling targeted examination for individuals with oligogenic or unclear phenotypes or where standalone clinical testing is unavailable ([providers.genedx.com](https://providers.genedx.com/Resources/TIS-Files/TIS-TG70-706-J757.5.2024.pdf?utm_source=openai)).
Special Instructions
Providers must submit a custom gene list via the GeneDx Slice Tool; upon approval (within 3 business days), GeneDx returns a tracking number that must accompany specimen submission; prior exome analysis is required and results are limited to the requested list—secondary findings are not reported unless included in the gene list ([providers.genedx.com](https://providers.genedx.com/Resources/TIS-Files/TIS-TG70-706-J757.5.2024.pdf?utm_source=openai)).
Limitations
Only variants in the provider’s approved gene list are analyzed and reported; whole-exome data are generated but secondary ACMG findings not on the custom list will not be identified; provider bears responsibility for gene selection; the gene list and panel content may change at any time ([providers.genedx.com](https://providers.genedx.com/Resources/TIS-Files/TIS-TG70-706-J757.5.2024.pdf?utm_source=openai)).
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided